| 33.76 Real-Time Quote | -1.43 / -4.06%Today’s Change | 11.19 Today|||52-Week Range 40.27 | +111.00% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 42.50, with a high estimate of 60.00 and a low estimate of 36.00. The median estimate represents a +25.89% increase from the last price of 33.76.

The current consensus among 4 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




